ZAI LAB LIMITED Deferred Income Tax Assets, Net
ZAI LAB LIMITED (ZLAB) had Deferred Income Tax Assets, Net of $4.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-06
- 2026-06-30: Deferred Income Tax Assets, Net $4.85M.
- 2026-03-31: Deferred Income Tax Assets, Net $3.44M.
- 2025-12-31: Deferred Income Tax Assets, Net $3.39M.
- 2024-12-31: Deferred Income Tax Assets, Net $0.00.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $4.85M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $3.44M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.39M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |